TerminatedPhase 4

Effectivity of Postpartum Dexamethasone for Women With Class I HELLP Syndrome

Stopped: The speed of recruitment was slower than anticipated.

Brazil400 participantsStarted 2011-07

Plain-language summary

Corticotherapy accelerates maternal postpartum recovery in women with class I HELLP syndrome. The benefit of faster and better recovery would be observed in fewer complications, less utilization of blood products and shorter hospital stay.

Who can participate

Age range13 Years – 49 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Postpartum women with Class I HELLP syndrome Exclusion Criteria: * Chronic users of corticosteroids * Patients with chronic conditions affecting the laboratory parameters involved in the HELLP syndrome * Women who had received antenatal corticosteroids to treat HELLP syndrome were excluded

What they're measuring

severe maternal morbidity

Timeframe: postpartum

Trial details

NCT IDNCT00711841

SponsorInstituto Materno Infantil Prof. Fernando Figueira

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2019-06

View on ClinicalTrials.gov More HELLP Syndrome trials